| Application number | Title of the application | Filing Date | Status |
|---|
| 09/581308 | Therapeutic use of lentiviral vectors | Feb 8, 2001 | Abandoned |
Array
(
[id] => 6099318
[patent_doc_number] => 20020053093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Methods of assaying receptor activity and constructs useful in such methods'
[patent_app_type] => new
[patent_app_number] => 09/772644
[patent_app_country] => US
[patent_app_date] => 2001-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18078
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20020053093.pdf
[firstpage_image] =>[orig_patent_app_number] => 09772644
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/772644 | Methods of assaying receptor activity and constructs useful in such methods | Jan 29, 2001 | Issued |
Array
(
[id] => 6294878
[patent_doc_number] => 20020056144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => 'Transgenic animal models for cardiac hypertrophy and methods of use thereof (screening)'
[patent_app_type] => new
[patent_app_number] => 09/772503
[patent_app_country] => US
[patent_app_date] => 2001-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 26091
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20020056144.pdf
[firstpage_image] =>[orig_patent_app_number] => 09772503
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/772503 | Transgenic animal models for cardiac hypertrophy and methods of use thereof (screening) | Jan 28, 2001 | Abandoned |
Array
(
[id] => 6020482
[patent_doc_number] => 20020104110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Immunologically privileged cells and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/770601
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18105
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20020104110.pdf
[firstpage_image] =>[orig_patent_app_number] => 09770601
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/770601 | Immunologically privileged cells and uses thereof | Jan 25, 2001 | Issued |
Array
(
[id] => 6927753
[patent_doc_number] => 20050241010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Method for functional mapping of an alzheimer\'s disease gene network and for identifying therapeutic agents for the treatment of alzheimer\' s disease'
[patent_app_type] => utility
[patent_app_number] => 10/182087
[patent_app_country] => US
[patent_app_date] => 2001-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16232
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20050241010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182087
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182087 | Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer' s disease | Jan 22, 2001 | Abandoned |
Array
(
[id] => 5803708
[patent_doc_number] => 20020010947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Transgenic mouse model of human neurodegenerative disease'
[patent_app_type] => new
[patent_app_number] => 09/767088
[patent_app_country] => US
[patent_app_date] => 2001-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6801
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010947.pdf
[firstpage_image] =>[orig_patent_app_number] => 09767088
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/767088 | Transgenic mouse model of human neurodegenerative disease | Jan 21, 2001 | Abandoned |
Array
(
[id] => 33082
[patent_doc_number] => 07785882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Neuronal progenitor cells from hippocampal tissue and a method for isolating and purifying them'
[patent_app_type] => utility
[patent_app_number] => 10/181329
[patent_app_country] => US
[patent_app_date] => 2001-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 41
[patent_no_of_words] => 10419
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/785/07785882.pdf
[firstpage_image] =>[orig_patent_app_number] => 10181329
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181329 | Neuronal progenitor cells from hippocampal tissue and a method for isolating and purifying them | Jan 17, 2001 | Issued |
| 09/750456 | Novel mutated mammalian cells and animals | Dec 27, 2000 | Abandoned |
Array
(
[id] => 5987367
[patent_doc_number] => 20020099025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Treatment of neurological disorders'
[patent_app_type] => new
[patent_app_number] => 09/748657
[patent_app_country] => US
[patent_app_date] => 2000-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13077
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099025.pdf
[firstpage_image] =>[orig_patent_app_number] => 09748657
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/748657 | Treatment of neurological disorders | Dec 21, 2000 | Abandoned |
| 09/623565 | Identification of pactolus: a beta integrin-like protein | Dec 11, 2000 | Abandoned |
Array
(
[id] => 6797792
[patent_doc_number] => 20030176666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Hypothalamus-specific polypeptides\n'
[patent_app_type] => new
[patent_app_number] => 09/735138
[patent_app_country] => US
[patent_app_date] => 2000-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25814
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176666.pdf
[firstpage_image] =>[orig_patent_app_number] => 09735138
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/735138 | Hypothalamus-specific polypeptidesn | Dec 11, 2000 | Abandoned |
Array
(
[id] => 6948063
[patent_doc_number] => 20010021699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-13
[patent_title] => 'Therapeutic and drug screening methods for the treatment and prevention of neuronal disease'
[patent_app_type] => new
[patent_app_number] => 09/735066
[patent_app_country] => US
[patent_app_date] => 2001-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 21653
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20010021699.pdf
[firstpage_image] =>[orig_patent_app_number] => 09735066
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/735066 | Methods for enhancing survival of a neuron | Dec 10, 2000 | Issued |
Array
(
[id] => 6851534
[patent_doc_number] => 20030143737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Long-term cell-culture compositions and genetically modified animals derived therefrom'
[patent_app_type] => new
[patent_app_number] => 09/732520
[patent_app_country] => US
[patent_app_date] => 2000-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 9661
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143737.pdf
[firstpage_image] =>[orig_patent_app_number] => 09732520
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/732520 | Long-term cell-culture compositions and genetically modified animals derived therefrom | Dec 6, 2000 | Abandoned |
Array
(
[id] => 1235491
[patent_doc_number] => 06689610
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-10
[patent_title] => 'Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same'
[patent_app_type] => B1
[patent_app_number] => 09/724962
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 15295
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/689/06689610.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724962
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724962 | Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same | Nov 27, 2000 | Issued |
| 09/701156 | Gene expression method | Nov 21, 2000 | Abandoned |
Array
(
[id] => 919968
[patent_doc_number] => 07321074
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-01-22
[patent_title] => 'Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight'
[patent_app_type] => utility
[patent_app_number] => 10/129599
[patent_app_country] => US
[patent_app_date] => 2000-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 47
[patent_no_of_words] => 21522
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/321/07321074.pdf
[firstpage_image] =>[orig_patent_app_number] => 10129599
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/129599 | Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight | Nov 8, 2000 | Issued |
Array
(
[id] => 1287563
[patent_doc_number] => 06639123
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-28
[patent_title] => 'Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight'
[patent_app_type] => B1
[patent_app_number] => 09/709066
[patent_app_country] => US
[patent_app_date] => 2000-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 46
[patent_no_of_words] => 22696
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/639/06639123.pdf
[firstpage_image] =>[orig_patent_app_number] => 09709066
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/709066 | Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight | Nov 8, 2000 | Issued |
Array
(
[id] => 3716
[patent_doc_number] => 07811557
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-10-12
[patent_title] => 'Methods for improving central nervous system functioning'
[patent_app_type] => utility
[patent_app_number] => 09/698893
[patent_app_country] => US
[patent_app_date] => 2000-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 4762
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/811/07811557.pdf
[firstpage_image] =>[orig_patent_app_number] => 09698893
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/698893 | Methods for improving central nervous system functioning | Oct 26, 2000 | Issued |
| 09/693043 | Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain | Oct 19, 2000 | Abandoned |
Array
(
[id] => 397365
[patent_doc_number] => 07294333
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-11-13
[patent_title] => 'Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues'
[patent_app_type] => utility
[patent_app_number] => 09/691889
[patent_app_country] => US
[patent_app_date] => 2000-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 31
[patent_no_of_words] => 12438
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/294/07294333.pdf
[firstpage_image] =>[orig_patent_app_number] => 09691889
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/691889 | Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues | Oct 19, 2000 | Issued |